Highlights

• Silex Systems Limited (ASX:SLX) owns 51% of Global Laser Enrichment.

• GLE’s proposed Paducah Facility would use SILEX laser enrichment technology.

• The commercial framework covers proposed natural and enriched uranium output.

• Licensing, financing and a final Investment decision remain outstanding.

Silex Systems Limited (ASX:SLX) is advancing the commercial framework for Global Laser Enrichment’s proposed Paducah facility. The latest arrangements cover Marketing and offtake for proposed uranium products, while licensing, financing and a final investment decision remain outstanding.

A long-running nuclear technology bet

Silex Systems is an Australian technology company that has spent more than two decades developing SILEX, a laser-based uranium enrichment process, which it licenses to GLE. GLE is a US joint venture originally formed with GE-Hitachi before Cameco bought in, lifting its stake from 24 per cent to 49 per cent in a 2021 restructuring that left Silex with the majority 51 per cent holding. GLE's flagship project is a proposed commercial enrichment facility at Paducah, Kentucky, designed around rights to re-enrich vast stockpiles of depleted uranium tailings left over from the site's Cold War-era gaseous diffusion operations, rather than starting from freshly mined ore.

What the Cameco agreement covers

Under the new agreement, Cameco becomes the exclusive marketer of GLE's future output, spanning natural uranium hexafluoride and enriched products including low-enriched uranium, LEU+ (enriched to between 5 and 10 per cent U-235) and high-assay low-enriched uranium (HALEU). GLE is expected to draw on more than 200,000 tonnes of existing depleted uranium tails at Paducah to produce roughly 70,000 tonnes of 'fresh feed' material over the plant's operating life. Rather than build its own sales and marketing arm, GLE will receive pricing linked to Cameco's average realised price, net of selling costs, an arrangement designed to give the venture predictable Revenue without the cost of a standalone trading desk.

Why it matters commercially

Nuclear fuel buyers have been reluctant to commit to enrichment capacity that does not yet exist, and GLE has needed a credible partner to help de-risk financing before committing billions of dollars to construction. For Silex, whose SILEX laser technology underpins the whole venture, a firmer commercial pathway for GLE also supports the long-term case for Royalty and technology-licensing income alongside its majority Equity stake in the project, at a time when interest in Australian-linked nuclear fuel-cycle technology has been rising among domestic investors.

Key Insights

GLE has not yet made a final investment decision to build the Paducah plant, and the company expects the relevant US Nuclear Regulatory Commission licence approval only in early 2027. Construction timelines, total Capital cost and the ultimate financing structure, including how much Debt versus equity the venture will need, have not been detailed publicly. Cameco separately retains an option to lift its GLE stake to as much as 75 per cent, which would dilute Silex's economic interest if exercised.